Free Trial

Wall Street Zen Downgrades Haleon (NYSE:HLN) to Hold

Haleon logo with Medical background

Wall Street Zen lowered shares of Haleon (NYSE:HLN - Free Report) from a buy rating to a hold rating in a report issued on Saturday morning.

Several other equities research analysts also recently issued reports on the stock. Barclays reissued an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a research report on Friday, May 9th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a report on Tuesday, May 27th. Finally, BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Six analysts have rated the stock with a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Check Out Our Latest Research Report on HLN

Haleon Stock Down 1.7%

Shares of NYSE:HLN traded down $0.17 during trading on Friday, reaching $9.74. 7,562,290 shares of the company traded hands, compared to its average volume of 9,679,588. The firm has a market cap of $43.73 billion, a P/E ratio of 24.99, a price-to-earnings-growth ratio of 2.88 and a beta of 0.25. Haleon has a 1-year low of $8.68 and a 1-year high of $11.42. The company has a quick ratio of 0.78, a current ratio of 0.98 and a debt-to-equity ratio of 0.53. The firm has a fifty day simple moving average of $10.70 and a 200 day simple moving average of $10.17.

Institutional Trading of Haleon

Several institutional investors and hedge funds have recently made changes to their positions in HLN. FMR LLC increased its holdings in Haleon by 3.7% in the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after buying an additional 3,909,545 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Haleon by 22.0% in the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company's stock worth $192,428,000 after acquiring an additional 3,372,155 shares during the last quarter. Sculptor Capital LP lifted its holdings in shares of Haleon by 22.1% in the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company's stock valued at $111,645,000 after purchasing an additional 1,962,770 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of Haleon by 0.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock valued at $72,793,000 after purchasing an additional 58,444 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Haleon by 18.3% during the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock worth $57,382,000 after buying an additional 930,701 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Company Profile

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Articles

Analyst Recommendations for Haleon (NYSE:HLN)

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines